Marex Group’s Enovis ENOV Stock Holding History

Marex Group’s Portfolio ENOV Stock Details ENOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-15,300	Closed	-$348K	–	1201
2026 Q1	$348K	Sell	15,300 -1	-0%	-$24	﹤0.01%	726
2025 Q4	$408K	Buy	15,301 +3,501	+30%	+$103K	﹤0.01%	622
2025 Q3	$358K	Buy	+11,800	New	+$358K	﹤0.01%	580

Other funds holding ENOV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Marex Group's ENOV Position: Q2 2026 in Review

Marex Group sold out of Enovis (ENOV) in Q2 2026, closing a stake of 15,300 shares — an estimated $348K sold.

Marex Group first reported a position in ENOV in Q3 2025 and held it in 3 quarters. The position peaked at $408K in Q4 2025. 251 funds tracked by Wall St. Rank hold ENOV as of Q2 2026.

Marex Group reported no remaining Enovis position as of Q2 2026 after selling out during the quarter.
Marex Group sold 15,300 Enovis shares in Q2 2026, an estimated $348K.
Marex Group first reported a position in Enovis in Q3 2025 and held it in 3 quarters.
Marex Group's Enovis position peaked at $408K in Q4 2025.
251 funds tracked by Wall St. Rank held Enovis as of Q2 2026.

Based on Marex Group's 13F filing for Q2 2026, filed 14 Aug 2026.